A study conducted by a team of U.S. researchers found that financial ties between researchers and the companies that make the drugs they are studying are independently associated with positive trial results. The team’s work was published in The BMJ this week.
The study was observational, so the results can’t be used to draw concrete conclusions. But the authors write that since industry and academia collaborate to advance many new treatments, “more thought needs to be given to the roles that investigators, policy makers, and journal editors can play in ensuring the credibility of the evidence base.”
Get the full story at our sister site, Drug Delivery Business News.
The post Study finds financial ties between researchers, industry associated with positive trial results appeared first on MassDevice.